December 2, 2015
Menlo Park, CA
The post-grant opposition procedure at the European Patent Office (EPO) is a powerful tool. More than two-thirds of European patents that are opposed end up being either narrowed in scope or revoked entirely. With applicants from the United States receiving the most European patent grants, understanding how the EPO opposition procedure works, from both offensive and defensive perspectives, will form a key part of any U.S. practitioner’s international patent strategy.
Developing consistent strategies and knowing how to take advantage of both the similarities and the differences between EPO oppositions and U.S. post-grant challenges can give rise to time and cost efficiencies, while ensuring consistent and optimized strategies in each jurisdiction. Please join Finnegan’s European Patent Attorneys as they discuss the following topics and provide practical tips and insights:
Speakers:
M. Paul Barker
Aaron J. Capron
Philip L. Cupitt, Ph.D.
Martin D. Hyden
Date:
Wednesday, December 2, 2015
Time:
1:15 - 1:30 p.m. – Registration
1:30 - 4:30 p.m. – Seminar
4:30 - 5:30 p.m. – Reception
Location:
Menlo Park, CA
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Panel Discussion
May 5, 2026
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.